Opportunity
DIBBS #SPE2DP-26-T-3819
DLA Solicitation for Moxifloxacin Hydrochloride Tablets (400 mg, 30-count) for Navy Vessels
Posted
June 17, 2026
Respond By
June 22, 2026
Identifier
SPE2DP-26-T-3819
NAICS
424210
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain Pharmacy FSA is seeking quotations for Moxifloxacin Hydrochloride Tablets for delivery to two U.S. Navy vessels. - Government Buyer: - Defense Logistics Agency (DLA), Troop Support Medical Supply Chain Pharmacy FSA - OEMs (Original Equipment Manufacturers): - TEVA PHARMACEUTICALS USA, INC. - RISING PHARMA HOLDINGS, INC. - Products Requested: - Moxifloxacin Hydrochloride Tablets, 400 mg, 30 tablets per bottle - NSN: 6505-01-503-4772 - Part Numbers: NDC00093-7387-56 (TEVA), NDC57237-0156-30 (RISING PHARMA) - Total Quantity: 20 bottles (15 for USS Roosevelt DDG 80, 5 for USS Lewis B Puller ESB 3) - Notable Requirements: - Only FDA-regulated, shelf-stable (36 months, non-extendable) products from approved manufacturers - Packaging and marking must comply with Medical Marking Standard No. 1 and DLA requirements - Delivery required within 20 days to specified Navy vessels - FOB destination applies for all deliveries
Description
MOXIFLOXACIN HYDROC (QTY: 5, NSN: 6505-01-503-4772, Purchase Request: 7017192160) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
MOXIFLOXACIN HYDROC (QTY: 15, NSN: 6505-01-503-4772, Purchase Request: 7017190258) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.